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SYMPoSIUM
Progress in Complementary and Alternative
Medicine Research
Yale Research Symposium on Complementary and
Integrative Medicine
John D. Millet
Yale University School of Medicine, New Haven, Connecticut
Integrative Medicine at Yale and the Yale Center for Continuing Medical Education (CME†)
sponsored the Yale Research Symposium on Complementary and Integrative Medicine in
March 2010 at the university’s School of Medicine. Delivering the keynote address, Dr.
Josephine P. Briggs, Director of the National Center for Complementary and Alternative
Medicine (NCCAM) at the National Institutes of Health (NIH), highlighted recent progress
made in the field of complementary and alternative medicine (CAM).
Complementary and alternative medi-
cine (CAM) encompasses a wide range of
therapies, systems, and products that are
used along with or in place of conventional
medical care. According to the National
Center for Health Statistics, approximately
38 percent of adults and 12 percent of chil-
dren in the United States are using some
form of CAM [1]. The most common CAM
therapies  include  non-vitamin  and  non-
mineral natural products, deep breathing
exercises, meditation, chiropractic or os-
teopathic manipulation, massage, and yoga
[1]. Though scientific evidence supports
the utility of some CAM therapies, key
questions regarding safety and efficacy pre-
vent many of these treatments from being
adopted into mainstream care. Those that
are adopted must present some evidence of
safety and effectiveness and are often com-
bined with conventional healthcare, result-
ing in a field known as integrative medicine
[2].
Given the popularity of CAM, many
medical schools have begun to address it in
their  curricula,  establish  CAM  research
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ory; FDA, Food and Drug Administration.centers, and form CAM interest groups. In-
tegrative Medicine at Yale, established in
2007, is an interest group at the university’s
School of Medicine that provides a forum
for Yale students, faculty, and clinicians to
research  and  discuss  CAM  therapies.  In
March 2010, Integrative Medicine at Yale
and the Yale Center for Continuing Medical
Education (CME) brought together more
than 170 clinicians, researchers, and stu-
dents for the Yale Research Symposium on
Complementary and Integrative Medicine.
In her keynote address, Dr. Josephine P.
Briggs, Director of the National Center for
Complementary and Alternative Medicine
(NCCAM)  at  the  National  Institutes  of
Health (NIH), observed that many of the
large, prospective clinical studies funded by
NCCAM in recent years have not yielded
positive results. For example, the Ginkgo
Evaluation of Memory (GEM) study, pub-
lished in 2009, found that regular use of
Ginkgo bilobadid not slow cognitive decline
in older adults with normal cognition or mild
cognitive  impairment,  as  compared  to
placebo  [3].  Similar  rigorous  NCCAM-
funded studies of using St. John’s Wort for
treating major depression [4], glucosamine
and chondroitin for treating osteoarthritis
[5,6], and echinacea for preventing and treat-
ing the common cold [7] also found these
popular CAM therapies to be ineffective.
Despite the negative outcomes of recent
studies,  Briggs  noted  the  importance  of
NCCAM-sponsored investigations. While
efficacy  testing  may  not  always  lead  to
novel treatments, it does inform the public
and has an effect on CAM use patterns.
Sales of echinacea products, for example,
substantially declined following publication
of NCCAM’s echinacea trial in July 2005
[8]. Briggs reported that a similar decline in
sales of Ginkgo biloba products is expected
due  to  publication  of  the  GEM  study.
NCCAM also has made it a priority to dis-
seminate  reliable,  up-to-date  information
about CAM therapies on its Web site in an
effort to further increase the public impact
of NCCAM-funded research.
In addition to supporting clinical inves-
tigations, NCCAM has worked to increase
knowledge of the quality and safety of CAM
products currently on the market. Briggs
highlighted a 2008 NCCAM-funded study
that found that one in five U.S.- and Indian-
manufactured Ayurvedic supplements pur-
chased online contains detectable amounts
of arsenic, mercury, and lead [9]. This find-
ing prompted the Food and Drug Adminis-
tration  (FDA)  to  issue  an  alert  about
Ayurvedic products, helping to increase pub-
lic awareness of natural product safety is-
sues. Additionally, to ensure the quality and
safety of herbal and other natural products
used  in  research,  NCCAM’s  Product  In-
tegrity Working Group rigorously investi-
gates  all  CAM  products  to  be  used  in
NCCAM-funded studies.
Many  new  horizons  have  opened  as
CAM research matures and several CAM-re-
lated research areas have yet to be explored.
According to Briggs, promising avenues of
future CAM research include determining
the  molecular  targets  of  quercetins,  cur-
cumin, polyphenols, and other dietary small
molecules; the active components of tradi-
tional Chinese medicines; the anti-inflam-
matory  effects  of  omega-3  fatty  acids  at
clinically significant concentrations; the ef-
fects of pre- and probiotics on the human mi-
crobiome; the neuroscience of mind-body
interventions; the benefits of yoga and tai-chi
for maintaining balance and avoiding falls in
elderly  patients;  and  the  contribution  of
mind-body practices to symptom (especially
pain) management. 
Briggs concluded by emphasizing that
NCCAM  is  dedicated  to  encouraging  an
open and informed dialogue between health-
care practitioners and their patients regard-
ing CAM. Indeed, given CAM’s popularity
among  patients,  NCCAM’s  effort  to
strengthen the science of CAM may be most
valuable if it helps to improve patient care
in clinical settings.
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